Market Tracker

02/28 7:34am ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

39.85
Delayed Data
As of Feb 27
 +0.97 / +2.49%
Today’s Change
17.02
Today|||52-Week Range
42.49
+38.18%
Year-to-Date
ACADIA Pharma (ACAD) Q4 Earnings: What's in Store this Time?
Feb 23 / Zacks.com - Paid Partner Content
Caution: Acadia Pharmaceuticals Is Overvalued
Feb 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close38.88
Today’s open38.78
Day’s range38.75 - 40.09
Volume2,264,477
Average volume (3 months)2,544,343
Market cap$4.8B
Dividend yield--
Data as of 02/27/2017

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-43.71%
Earnings growth (next 5 years)+15.31%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book20.34

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc+0.20+2.37%
TAROTaro Pharmaceutical ...+0.35+0.30%
PTHNPatheon NV-0.30-0.92%
GRFSGrifols SA-0.02-0.11%
Data as of 02/27/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts